SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- obesity/erectile dysfunction -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (113)8/3/2003 5:19:54 PM
From: Miljenko Zuanic  Respond to of 435
 
From analysts and street perspective P57 was one of the very promising candidate. It points out that first priority is *clean* compound, with well defined mode of action and generated medical benefit.

Obesity continue to be holy grail, but with high failure rate.

Miljenko